Editing eIF4E in the Watermelon Genome Using CRISPR/Cas9 Technology Confers Resistance to ZYMV
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252111468 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Maoying Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Vegetable Research Center, Beijing Academy of Agricultural and Forestry Sciences, Beijing 100097, China. Hauptthemen laut MEDLINE: Citrullus, CRISPR-Cas Systems, Gene Editing, Disease Resistance. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the construction of cucurbits collaboration and innovation center, Scientific and Technological Innovation Capacity Construction Special Funds of Beijing Acade-my of Agriculture and Forestry.
Abstract (Originalsprache)
Watermelon is one of the most important cucurbit crops, but its production is seriously affected by viral infections. Although eIF4E proteins have emerged as the major mediators of the resistance to viral infections, the mechanism underlying the contributions of eIF4E to watermelon disease resistance remains unclear. In this study, three CleIF4E genes and one CleIF(iso)4E gene were identified in the watermelon genome. Among these genes, CleIF4E1 was most similar to other known eIF4E genes. To investigate the role of CleIF4E1, CRISPR/Cas9 technology was used to knock out CleIF4E1 in watermelon. One selected mutant line had an 86 bp deletion that resulted in a frame-shift and the expression of a truncated protein. The homozygous mutant exhibits developmental defects in plant growth, leaf morphology and reduced yield. Furthermore, the mutant was protected against the zucchini yellow mosaic virus, but not the cucumber green mottled mosaic virus. In summary, this study preliminarily clarified the functions of eIF4E proteins in watermelon. The generated data will be useful for elucidating eIF4E-related disease resistance mechanisms in watermelon. The tissue-specific editing of CleIF4E1 in future studies may help to prevent adverse changes to watermelon fertility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Vegetable Research Center, Beijing Academy of Agricultural and Forestry Sciences, Beijing 100097, China.
- College of Horticulture, Hunan Agricultural University, Changsha 410128, China.
ORCID-Profile: Maoying Li, Shouwei Tian
Förderung
- National Natural Science Foundation of China
- the construction of cucurbits collaboration and innovation center
- Scientific and Technological Innovation Capacity Construction Special Funds of Beijing Acade-my of Agriculture and Forestry
- Collaborative Innovation Center of BAAFS
- scientist training program of BAAFS
- Ministry of Agriculture and Rural Affairs of China
- construction of cucurbits collaboration and innovation center
- Scientific and Technological Innovation Capacity Construction Special Funds of Beijing Academy of Agriculture and Forestry
Zitieren
APA
Li, M., Qiu, Y., Zhu, D., Xu, X., Tian, S., Wang, J., Yu, Y., Ren, Y., Gong, G., Zhang, H., Xu, Y., & Zhang, J. (2024). Editing eIF4E in the Watermelon Genome Using CRISPR/Cas9 Technology Confers Resistance to ZYMV. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111468
Vancouver
Li M, Qiu Y, Zhu D, Xu X, Tian S, Wang J, et al. Editing eIF4E in the Watermelon Genome Using CRISPR/Cas9 Technology Confers Resistance to ZYMV. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111468
BibTeX
@article{Li2024,
author = {Li, Maoying and Qiu, Yanhong and Zhu, Dongyang and Xu, Xiulan and Tian, Shouwei and Wang, Jinfang and Yu, Yongtao and Ren, Yi and Gong, Guoyi and Zhang, Haiying and Xu, Yong and Zhang, Jie},
title = {Editing eIF4E in the Watermelon Genome Using CRISPR/Cas9 Technology Confers Resistance to ZYMV},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252111468}
}
EUVIMED